Hetero launches antiviral Covid-19 drug favipiravir at Rs 59 per tablet



Drug firm Hetero on Wednesday said it has launched genericoral antiviral drug Favipiravir used forthe treatment of patients with mild to moderate Covid-19,in India under the brand name 'Favivir' at Rs 59 per tablet.

The company has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI), Hetero said in a statement.

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19, it added.

Themedication has demonstrated positive clinical outcomes. It improves treatment accessibility to a significant amount of Covid-19 patient population, which have mild to moderate symptoms, Hetero said. Read More


Comments

Popular posts from this blog

Budgeting Myths Busted: 7 Common Misconceptions Revealed

India to test 100-yr-old vaccine on adults as war on Covid-19 hots up

Top 10 best finance movies to binge on your long weekend